CL4-modified exosomes deliver lncRNA DARS-AS1 siRNA to suppress triple-negative breast cancer progression and attenuate doxorubicin resistance by inhibiting autophagy

Xinli Liu, Ge Zhang, Tongyao Yu, Jie Liu, Xiaoxia Chai, Dachuan Yin, Chenyan Zhang

科研成果: 期刊稿件 › 文章 › 同行评审

30 引用 （Scopus）

指纹

探究 'CL4-modified exosomes deliver lncRNA DARS-AS1 siRNA to suppress triple-negative breast cancer progression and attenuate doxorubicin resistance by inhibiting autophagy' 的科研主题。它们共同构成独一无二的指纹。

Pharmacology, Toxicology and Pharmaceutical Science